Humanwell Healthcare (600079.SH): The hydrochloride abidol tablets have obtained the drug registration certificate.

09/04/2025

GMT Eight

Humanwell Healthcare (600079.SH) announced that its holding subsidiary, Wuhan Renfulicon Pharmaceutical Co., Ltd. (referred to as "Renfulicon"), recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for Abidol Hydrochloride Tablets. The announcement shows that Abidol Hydrochloride Tablets are used to treat upper respiratory infections caused by influenza A and B viruses.

Tariff clouds are difficult to shake the resilience of the tourism industry. Global travel spending hits a historic high against the trend.

Shinva Medical Instrument (600587.SH) : "Medical electronic linear accelerator" has obtained Class III medical device registration certificate.

Contact: [email protected]

Humanwell Healthcare (600079.SH): The hydrochloride abidol tablets have obtained the drug registration certificate.

RECOMMEND

Significantly lower the target price for US stocks, Wall Street "torn reports", but still insist "will rise this year"

Industrial: Currently, the market is experiencing ups and downs, focusing on internal certainty and defending against potential threats on three major fronts.

New Stock Outlook: Will the price increase of main products slow down, prompting Zhihui Mining to shift towards underground mining to increase production and compensate for the price?